Vaginal lIve Biotherapeutic(Massachusetts General Hospital)
N/A
Report date: 2024/03/01 20:05:21
Base Information
Drug NameVaginal lIve Biotherapeutic(Massachusetts General Hospital)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMassachusetts General HospitalBill And Melinda Gates FoundationRagon Institute Of Mgh, Mit And Harvard +[4]
China Registration ClassN/A
Develop Information
Active CompaniesRagon Institute Of Mgh, Mit And HarvardMassachusetts General HospitalCentre For The Aids Programme Of Research In South Africa +[4]
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A